DaVita (DVA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on DaVita (DVA) is Neutral.

The composite score behind that read is +0.00, weighing +0.15 of bullish evidence against -0.36 bearish.

DaVita last closed at $179.25, +1.26% on the session.

Against the IVW growth benchmark the position is +0.46% over the forecast window.

The read is built from 15 underlying insights — 8 bullish and 7 bearish.

Agreement across those insights is 47%.

4 graded predictions for DVA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks DaVita in the 63rd percentile on valuation and the 9th percentile on return on equity, where 100 is best.

DaVita is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $11.29B.

StockMap tracks DaVita as the 16th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite DaVita ranks 43rd of 85 in the group, against a group median of +0.00.

Other Health Care stocks

DaVita (DVA) — StockMap 2-week forecast & tracked accuracy